Navigation Links
deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer
Date:5/18/2008

to confer a 20% increased risk of CM and a 14% increase in risk of BCC compared to non-carriers. These increases in risk remain significant even after accounting for the effect of the pigmentation traits themselves on cancer risk. Furthermore, several other variants that deCODE has also linked to freckling and sensitivity to sun did not show any detectable link to skin cancer.

"It is common knowledge that people with fairer complexions tend to be more sensitive to the sun, and that extensive exposure to sun or repeated burning can increase the risk of skin cancers. But we are now showing that there are a variety of different genetic bases for what appear to be the same pigmentation characteristics, and we have demonstrated that certain of these carry with them greater risk of skin cancer than do others. This information is important for understanding the biology of skin cancers, particularly as it appears that these variants may be conferring some of this additional risk through a mechanism independent of their role in giving rise to sun-sensitive skin. These findings may also be useful for helping individuals to better gauge their susceptibility to skin cancer, and we are therefore very pleased to be including these variants in our deCODEme(TM) service," said Kari Stefansson, CEO of deCODE.

The papers, 'Two newly identified genetic determinants of pigmentation in Europeans' and 'ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma,' are published today in the online edition of Nature Genetics, at http://www.nature.com/ng, and will be published in an upcoming print edition of the journal.

This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics, by a subcontract agreement to deCODE Genetics under Westat contract N02-CP-91026 to the
'/>"/>

SOURCE deCODE
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. deCODE Obesity Study Sheds Light on How Genetics Affects Risk and Onset of Common Diseases
2. deCODE Launches a DNA-Based Test for Assessing Risk of Prostate Cancer on the Back of the Discovery of New Prostate Cancer Genes
3. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
4. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
5. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
6. St. Jude Discovers Factors That Accelerate Resistance to Gleevec(TM) Targeted Therapy in Lymphoblastic Leukemia
7. Video: New Research Discovers Independent Brain Networks Control Human Walking
8. National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair
9. Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial of Novel Bone Disease Therapy
10. Cytopia Announces Novel Anti-Cancer Drug Development Collaboration
11. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 2015   HeartWare International, Inc . (NASDAQ: HTWR ... technologies that are revolutionizing the treatment of advanced heart failure, ... is scheduled to present at the Bank of America Merrill ... on Thursday, May 14, 2015, at 10:00 a.m. ... the Company,s presentation at the conference will be available via ...
(Date:5/4/2015)... , May 4, 2015 MEI Pharma, ... focused on the clinical development of novel therapies ... mitochondria-specific effects of the Company,s investigational drug candidate ... activity when combined with a tyrosine-kinase inhibitor (TKI). ... to be a potent inhibitor of mitochondrial oxidative ...
(Date:5/4/2015)... JUPITER, Fla. , May 4, 2015 /PRNewswire/ ... global biotechnology company whose patented and proprietary technologies ... and other proteins for the bioenergy, bio-based chemical, ... it will report its financial results for quarter ... Thursday, May 14, 2015 and will host a ...
Breaking Medicine Technology:HeartWare Presentation At Bank Of America Merrill Lynch 2015 Health Care Conference To Be Webcast 2MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 2MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 3MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 4MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 5Dyadic International To Announce First Quarter 2015 Financial Results and Host Conference Call On Thursday, May 14, 2015 2Dyadic International To Announce First Quarter 2015 Financial Results and Host Conference Call On Thursday, May 14, 2015 3
... Papastavros, Associates has opened a new diagnostic ... digital X-ray, while two Newark centers offer CT, Open MRI ... eight centers throughout Delaware , plus a number of ... Town Center The new imaging center in ...
... 13, 2011 ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ... the previously announced sales of 8,184,556 units in a ... investors, and other institutional investors for a per unit ... of approximately $22.5 million.  Each unit consists of one ...
Cached Medicine Technology:Papastavros Opens New Radiology Centers in Delaware 2ADVENTRX Pharmaceuticals Announces Closing of $22.5 Million Financing 2ADVENTRX Pharmaceuticals Announces Closing of $22.5 Million Financing 3
(Date:5/4/2015)... 2015 CCL, a top-ranked, global provider ... program to other leadership development consultancies. “The CCL ... and successful practitioners, expanding our capacity to drive results ... John R. Ryan, CCL President and CEO. , As ... Partner Network , it will schedule a one-on-one conference ...
(Date:5/4/2015)... May 04, 2015 San Diego ... ceremony at their brand new, 13,700 square foot facility ... new building will not only provide fertility treatment and ... also offer community and educational events to a number ... is located next door to their current Carmel Valley/Del ...
(Date:5/4/2015)... Dr. Benjamin Stong of Kalos Facial ... latest non-surgical double-chin eliminator. Dr. Stong is double ... Atlanta to offer Kybella treatments . The FDA ... under the chin, promising to safely dissolve fat deposits ... who sought immediate solutions for their double chin were ...
(Date:5/4/2015)... 04, 2015 Unlike some camps, the Nike Middle ... The goal is to educate first and train second, with ... ensures that the young runners are building the knowledge base needed ... of the topics covered include Effort Based Training, Running Heroes, Running ... to be? This is not a camp where kids come ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Dr. Richard ... has been chosen to receive the America’s Best Dentist ... Dr. Champagne’s selection as a top dentist is a ... to continuing education and his compassion for his patients. ... professionals who exemplify excellence in their field. These nominees ...
Breaking Medicine News(10 mins):Health News:The Center for Creative Leadership Is Partnering with Lead Star to Create the CCL Partner Network 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3Health News:Facial Plastic Surgeon First in Atlanta To Offer Kybella Treatments To Reduce Chin Fat 2Health News:US Sports Camps and Select Nike Running Camps Offer Programs for Middle School Runners 2Health News:New Jersey Dentist Dr. Richard Champagne Nominated for America’s Best Dentist Award 2
... delivery combination selectively crosses the tight barrier that protects the ... to brain tumors, a research team led by scientists from ... the January issue of the Journal of Clinical Investigation ... the targeted particles guide payloads to image tumors, treat tumors, ...
... (HealthDay News) -- HIV-positive teens and young women are more likely ... who do not have HIV, a new study finds. Researchers ... aged 13 to 24, who had been treated at four hospitals ... some more than once, for a total of 96 pregnancies. ...
... By Serena Gordon HealthDay Reporter , TUESDAY, ... for profit are more likely to have patients who require ... who need longer times in hospice care, research reveals. ... hospices a flat daily rate, regardless of care needs -- ...
... research from University of Michigan says brain scans showing ... the person whose brain is being scanned. Emily ... recently led a study that scanned the brain activity ... would have an impact on their ability to quit ...
... from human placenta left over from live births and ... one kind of melatonin receptor, MT1. This potentially therapeutic ... laboratory test tube and animal models of stroke. ... with melatonin receptor MT2. Researchers from the University ...
... HealthDay Reporter , TUESDAY, Feb. 1 (HealthDay News) ... from meningococcal meningitis, a potentially deadly infection of the ... up-to-date whooping cough vaccines in light of recent outbreaks, ... American Academy of Pediatrics issues updated vaccination guidelines annually. ...
Cached Medicine News:Health News:Targeted particle fools brain's guardian to reach tumors 2Health News:Targeted particle fools brain's guardian to reach tumors 3Health News:Targeted particle fools brain's guardian to reach tumors 4Health News:HIV Linked to Higher Pregnancy Rate in Young Women 2Health News:For-Profit Hospices May Prefer Certain Types of Patients: Study 2Health News:For-Profit Hospices May Prefer Certain Types of Patients: Study 3Health News:Brain scans predict likely success when it comes to quitting smoking 2Health News:Transplanted human placenta-derived stem cells show therapeutic potential in stroke models 2Health News:Pediatricians Issue New Vaccination Recommendations 2Health News:Pediatricians Issue New Vaccination Recommendations 3
4 hour identification of over 70 medically important, oxidase-negative, gram-negative bacilli, including E. coli, based on enzyme technology....
Agglutinating sera for serological identification of E. coli by slide and/or tube agglutination tests. Agglutinating sera are packaged 2 mL / vial....
For presumptive identification of Escherichia coli using enzyme technology. Tests: Indole, MUG...
A direct qualitative enzyme immunoassay for detection of E.coli Shiga Toxin 1 and 2 in fresh or preserved fecal specimens....
Medicine Products: